These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 21335893

  • 1. Phenomenological model of laser-tissue interaction with application to Benign Prostatic Hyperplasia (BPH) simulation.
    Zhou X, Zhang N, Shen Y, Burke D, Konchada V, Sweet R.
    Stud Health Technol Inform; 2011; 163():749-55. PubMed ID: 21335893
    [Abstract] [Full Text] [Related]

  • 2. Laser surgery simulation platform: toward full-procedure training and rehearsal for benign prostatic hyperplasia (BPH) therapy.
    Shen Y, Konchada V, Zhang N, Jain S, Zhou X, Burke D, Wong C, Carson C, Roehrborn C, Sweet R.
    Stud Health Technol Inform; 2011; 163():574-80. PubMed ID: 21335859
    [Abstract] [Full Text] [Related]

  • 3. Volumetric modeling in laser BPH therapy simulation.
    Zhang N, Zhou X, Shen Y, Sweet R.
    IEEE Trans Vis Comput Graph; 2010; 16(6):1405-12. PubMed ID: 20975181
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Photoselective vaporization for benign prostatic hyperplasia.
    Murtagh J, Foerster V.
    Issues Emerg Health Technol; 2006 Dec; (95):1-4. PubMed ID: 17176529
    [Abstract] [Full Text] [Related]

  • 8. Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a review.
    Descazeaud A, Robert G, Azzousi AR, Ballereau C, Lukacs B, Haillot O, Dumonceau O, Devonec M, Fourmarier M, Saussine C, de la Taille A, Committee for lower urinary tract symptoms of the French Association of Urology.
    BJU Int; 2009 May; 103(9):1162-5. PubMed ID: 19154457
    [Abstract] [Full Text] [Related]

  • 9. Transurethral laser therapy and urinary tract infections.
    Miller J, Ludwig M, Schroeder-Printzen I, Schiefer HG, Weidner W.
    Ann Urol (Paris); 1996 May; 30(3):131-8. PubMed ID: 8766150
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urodynamic effects of Prolase 2 laser prostatectomy in benign prostatic hyperplasia.
    Van Erps P, Schapmans S, Cortvriend J, D'Hont C, Denis LJ.
    Acta Urol Belg; 1995 Sep; 63(3):39-43. PubMed ID: 7484521
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K, Heino A, Aaltomaa S, Ala-Opas M.
    Scand J Urol Nephrol; 2003 Sep; 37(6):487-93. PubMed ID: 14675922
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of 5α-reductase inhibition on benign prostatic hyperplasia treated by photoselective vaporization prostatectomy with the 120 Watt GreenLight HPS laser system.
    Strom KH, Gu X, Spaliviero M, Wong C.
    J Am Coll Surg; 2011 Feb; 212(2):244-50. PubMed ID: 21183365
    [Abstract] [Full Text] [Related]

  • 19. Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH).
    Spaliviero M, Araki M, Page JB, Wong C.
    Lasers Surg Med; 2008 Oct; 40(8):529-34. PubMed ID: 18798292
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.